Cargando…
IPCT: Integrated Pharmacogenomic Platform of Human Cancer Cell Lines and Tissues
(1) Motivation: The exponential increase in multilayered data, including omics, pathways, chemicals, and experimental models, requires innovative strategies to identify new linkages between drug response information and omics features. Despite the availability of databases such as the Cancer Cell Li...
Autores principales: | Shoaib, Muhammad, Ansari, Adnan Ahmad, Haq, Farhan, Ahn, Sung Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409836/ https://www.ncbi.nlm.nih.gov/pubmed/30813377 http://dx.doi.org/10.3390/genes10020171 |
Ejemplares similares
-
Integrated Primary Care Teams (IPCT) pilot project in Quebec: a protocol paper
por: Contandriopoulos, Damien, et al.
Publicado: (2015) -
Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer
por: Ansari, Adnan Ahmad, et al.
Publicado: (2018) -
Virtual Pharmacist: A Platform for Pharmacogenomics
por: Cheng, Ronghai, et al.
Publicado: (2015) -
Integration of a standardized pharmacogenomic platform for clinical decision support at Boston Children's Hospital
por: Brownstein, Catherine, et al.
Publicado: (2012) -
Integrating epigenomics into pharmacogenomic studies
por: Zhang, Wei, et al.
Publicado: (2008)